Ingenes

Ingenes, established in 2005, is a premier assisted reproduction and genetics institute dedicated to resolving complex fertility challenges. The company maintains the largest market share in Mexico for high-complexity fertility cases, leveraging extensive clinical experience to support patients. Recognized by the National Science and Technology Council (CONACYT), Ingenes holds prestigious international affiliations with the Latin America Network of Assisted Reproduction (RedLara) and the Fertility Centers of Illinois, ensuring adherence to global standards.

The organization currently operates across 4 strategic locations, supported by a dedicated workforce of 500-1,000 employees. Meet Ingenes's team to explore the multidisciplinary clinical expertise driving their comprehensive reproductive health services. Their operational model effectively integrates advanced fertility research with patient-centered care, specifically designed to minimize the physical, emotional, and financial stress typically associated with fertility treatments. This approach ensures that patients receive high-quality, evidence-based care throughout their reproductive journey.

Ingenes reports a newborn success rate via in vitro fertilization using a patient's own eggs that is 78% higher than the RedLara average and 10% above the average for fertility clinics in the United States. With over 1,000 successful births, the institute utilizes proprietary techniques in microarray analysis and specialized reproductive health communication platforms. Their commitment to high-complexity fertility treatment positions them as a dominant leader in the North American healthcare sector, consistently outperforming regional benchmarks in clinical outcomes and genetic research applications.